Bath & Body Works, Inc. (BBWI) stock analysis
Close on Nov 10, 2026Market cap $4.37BP/E 5.6Yield 3.70%
StockData Score
Prices as of Nov 11, 2026How the score works
Mixed14 of 30 checks passed
Bath & Body Works passes 14 of the 30 checks behind our score; 4 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 5/6
- Growth
- 2/6
- Past performance
- 2/6
- Financial health
- 2/6
- Dividend
- 3/6
What stands out
Margin of safety over 20%
The price is 51.5% below fair value, more than the 20% cushion we look for.
Trading below fair value
The share price of $21.65 is below our fair value estimate of $44.68.
Return on capital over 10%
Return on invested capital was 51.9%, above the 10% that usually covers the cost of capital.
Earnings growth accelerating
Net income grew 7.3% over the last twelve months, against a 5-year average of -5.1% a year.
What to watch
Earnings shrank over 5 years
Net income shrank 5.1% a year on average over the last five fiscal years.
Revenue growing under 10% a year
Revenue grew -1.2% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -3.2% a year over the last three fiscal years.
Interest not well covered
Operating income covers interest expense 4.5 times; we look for at least 5.
Valuation5/6
P/E below its 5-year median
Bath & Body Works's P/E of 5.6 is below its own 5-year median of 8.9.
P/E below the industry
Bath & Body Works's P/E of 5.6 is below the Miscellaneous Retail median of 17.9.
EV/EBITDA below its 5-year median
Bath & Body Works's EV/EBITDA of 6.0 is below its 5-year median of 8.1.
P/S above the industry
Bath & Body Works's price-to-sales of 0.61 is above the Miscellaneous Retail median of 0.24 (book value is negative, so we use sales).
Trading below fair value
The share price of $21.65 is below our fair value estimate of $44.68.
Margin of safety over 20%
The price is 51.5% below fair value, more than the 20% cushion we look for.
Growth2/6
Revenue growing under 10% a year
Revenue grew -1.2% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -3.2% a year over the last three fiscal years.
Earnings growth accelerating
Net income grew 7.3% over the last twelve months, against a 5-year average of -5.1% a year.
Growing slower than the industry
Revenue grew -2.2% over the last twelve months; the Miscellaneous Retail median is 2.6%.
Guidance raised
Bath & Body Works raised its full-year 2026 net sales outlook on Aug 26, 2026.
Gross margin slipping
Gross margin was 44.1% over the last twelve months, against 44.6% a year earlier.
Past performance2/6
Return on equity
Needs positive equity and five years of results.
Return on capital over 10%
Return on invested capital was 51.9%, above the 10% that usually covers the cost of capital.
Return on equity against the industry
Needs positive equity.
Earnings shrank over 5 years
Net income shrank 5.1% a year on average over the last five fiscal years.
Net margin below its 5-year average
Net margin was 10.8% over the last twelve months, against a 5-year average of 11.8%.
Net margin above the industry
Bath & Body Works's net margin of 10.8% is above the Miscellaneous Retail median of -2.5%.
Financial health2/6
Debt level
Needs debt and equity figures.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 35.2% of total debt.
Interest not well covered
Operating income covers interest expense 4.5 times; we look for at least 5.
Short-term assets cover short-term debts
Current assets are 1.20 times current liabilities.
Bankruptcy risk in the grey zone
The Altman Z-score is 2.34; above 3 is the safe zone and below 1.8 the distress zone.
Dividend3/6
Pays a dividend
Bath & Body Works paid dividends worth 3.7% of the share price over the last twelve months.
Yield below Treasuries
The 3.7% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; Bath & Body Works yields 3.7%.
Dividend was cut
The dividend per share fell by more than 10% at least once in the last 10 fiscal years.
Covered by earnings
Dividends take 20.7% of net income.
Covered by free cash flow
Dividends take 15.7% of free cash flow.
Fair value
How we estimate itOur estimate per share
$44.68
The share price is 52% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 13.4× | 8.9× | 17.9× | $51.31 | 44% |
| EV/EBITDA | 9.4× | 8.1× | 10.8× | $42.35 | 39% |
| Earnings power | 11.1% cost of equity | – | – | $32.45 | 17% |
| Fair value | $44.68 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 8.9
- Miscellaneous Retail median 17.9
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $133.90M
- Value traded per 1% price move
- $48.81M
Downside
Medium risk
- Typical loss in a bad month
- 20.6%
- Volatility (annualized)
- 61%
- Sharpe ratio, 1 year
- -0.16
- Beta to the S&P 500 (5Y)
- 1.25
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | -0.2% | -1.2% | +2.5% | -5.0% | |
| Gross profit | -1.4% | -0.7% | +0.6% | -4.8% | |
| Operating income | -11.1% | -6.5% | -6.8% | -6.4% | |
| Net income | -18.7% | -6.7% | -5.1% | -6.4% | |
| EPS, diluted | -13.9% | -3.2% | +0.7% | -3.0% | |
| Free cash flow | +31.1% | +2.0% | -13.7% | -4.0% | |
| Dividend per share | 0.0% | 0.0% | +21.7% | -8.8% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | -234.4% | -78.1% | -48.7% | |
| Return on assets | 13.9% | 7.8% | 13.1% | |
| Current ratio | 1.72 | 1.97 | 1.27 | |
| Debt to equity | -7.87 | -9.62 | -3.04 | |
| Net debt to EBITDA | 1.54× | 1.14× | – | |
| Interest coverage | 5.1× | 3.7× | 4.1× | |
| Inventory turnover | 6.7× | 3.6× | 5.7× | |
| Capex to revenue | 7.9% | 3.5% | 3.3% | |
| Diluted shares | 291M | 281M | 209M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Bath & Body Works generated $5.58B from operations and spent $6.42B on capital expenditure, dividends and share buybacks. 21% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 8.9% | 1.47× | -3.73× | -48.7% |
| FY2024 | 10.9% | 1.41× | -3.43× | -53.0% |
| FY2023 | 11.8% | 1.36× | -2.86× | -45.8% |
| FY2022 | 10.6% | 1.31× | -3.09× | -43.0% |
| FY2021 | 16.9% | 0.90× | -8.07× | -122.3% |
| FY2020 | 13.1% | 0.59× | -10.04× | -78.1% |
| FY2019 | -6.8% | 0.59× | -7.69× | 30.9% |
| FY2018 | 4.9% | 1.63× | -10.01× | -79.4% |
| FY2017 | 7.8% | 1.55× | -11.01× | -132.7% |
| FY2016 | 9.2% | 1.51× | -16.87× | -234.4% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$649.00M
- Cash generatingOperating cash flow above zero$1.10B
- Return on assets improvedROA up on the prior year14.6% → 13.3%
- Earnings backed by cashOperating cash flow above net income$1.10B vs $649.00M
- Less leverageLong-term debt to assets fell79.7% → 71.3%
- Better liquidityCurrent ratio rose1.48 → 1.27
- No dilutionShare count did not rise221M → 209M
- Gross margin improvedGross margin up on the prior year44.26% → 43.74%
- More efficientAsset turnover rose1.34 → 1.50
See a number that looks wrong?